Applications of the genO‑hFcγR mouse model

Broad range of applications in the fields of immuno-oncology, infectious diseases, inflammation and autoimmunity:

  • Assess the Fc-mediated effector function of biologics:
    • Evaluation of B-cell depletion following treatment with anti-CD20 antibodies
    • Testing the protective role of antibodies in the context of infection, such as influenza
    • Ex vivo assessment of antibody-dependent cellular cytotoxicity (ADCC) induced by different monoclonal antibodies
  • Rank Fc-engineered antibodies with enhanced or reduced binding to FcγR
  • Gain insight into the mechanism of action (MOA) of biologics

Features

  • Fully immunocompetent model
  • genO‑hFcγR mice have a human-like expression pattern
  • No expression of murine FcγR
  • Functional receptors enabling assessment of Fc-mediated effector functions

Model Delivery & Care

  • Read our FAQ on delivery & care here
  • Orders are made directly with genOway; breeding, housing and delivery are outsourced
  • Breeding facilities in the US and Europe through our trusted partners:
  • Quick, compliant, and reliable door-to-door delivery worldwide
  • Models with certified SOPF health status from AAALAC-accredited and PHS-assured professional breeders

Validation data

Discover related products to

genO‑hFcγR

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Fc receptor
ICP (multi-target)
Immune checkpoint

genO-hFcγR/hIgG1

Double-humanized genO-hFcγR/hIgG1 mouse model to improve the tolerability to human IgG1 therapeutic antibodies.

Fc receptor
ICP (multi-target)
PK/PD
Immune checkpoint

genO‑hFcγR/hFcRn

Double-humanized genO‑hFcγR/hFcRn mouse model to improve PK assessment of compounds with extended half-life through FcRn binders.

Inflammation
IgE
FceR1
Fc receptor
Allergy

genO‑hIgE/hFcεR1

Use the genO‑hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.

HSA
PK/PD
Fc receptor

genO‑hSA/hFcRn

Double humanized genO‑hSA/hFcRn mouse model as a cutting-edge platform for preclinical development of hSA and FcRn-oriented therapeutics.

HSA
PK/PD
Fc receptor
KO-Rep-Mix

genO‑hSA/hFcRn-RAG1KO

This upgraded, immunocompromised RAG1-/- version of our genO-hSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

FcgR
Fc receptor
TFRC
Drug shuttling

genO‑hTFRC/hFcγR

Double-humanized genO-hTFRC/hFcγR mouse model to improve biodistribution and enable drug shuttling through the blood-brain barrier (BBB).

Preclinical humanized genO‑hFcγR mouse model

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe